Ozempic works by mimicking a natural gut hormone called GLP-1 that your body already produces after eating. The drug’s active ingredient, semaglutide, binds to the same receptors as this hormone but stays active in your body for about a week instead of minutes. This triggers a cascade of effects: your pancreas releases more insulin, your stomach empties slower, and your brain receives stronger “full” signals. The result is lower blood sugar and, for many people, significant weight loss.
The Hormone It Copies
Every time you eat, your intestines release a hormone called GLP-1 (glucagon-like peptide-1). This hormone’s main job is to tell your pancreas to produce insulin when blood sugar rises after a meal. It also tells the pancreas to stop releasing glucagon, a different hormone that signals your liver to dump stored sugar into your bloodstream. Natural GLP-1 is broken down by enzymes within minutes, so its effects are brief.
Semaglutide is a modified version of GLP-1 with a fatty acid chain attached to it. That fatty acid chain latches onto a protein in your blood called albumin, essentially hitching a ride through your circulatory system. This is what gives semaglutide a half-life of about 160 hours (roughly a week) compared to the few minutes natural GLP-1 survives. It’s why you only need one injection per week.
What Happens in Your Pancreas
When semaglutide reaches your pancreas, it locks onto GLP-1 receptors on the surface of insulin-producing beta cells. This triggers a chain reaction inside those cells: an enzyme called adenylate cyclase gets activated, which raises levels of a signaling molecule called cyclic AMP, which in turn switches on a protein that causes the cell to release its stored insulin.
Crucially, this process is glucose-dependent. The insulin release ramps up when your blood sugar is high and scales back when it’s normal. This is a key safety feature that makes semaglutide different from older diabetes drugs that could push blood sugar dangerously low. At the same time, semaglutide suppresses glucagon release from neighboring alpha cells in the pancreas, which reduces the amount of sugar your liver produces between meals. The combined effect in real-world use: patients on the 1.0 mg weekly dose see an average HbA1c reduction of 1.2 percentage points, and those who stay on the medication consistently see reductions closer to 1.4 points.
How It Affects Your Brain and Appetite
Lowering blood sugar is only part of the story. Semaglutide also crosses into or signals through the brain, and this is where much of the weight loss effect comes from.
Research published in Cell Metabolism has mapped the specific pathway. Semaglutide activates GLP-1 receptors on neurons in a brain region called the area postrema, which sits in the brainstem and acts as a sensor for circulating signals. Those neurons then activate a neighboring cluster of nerve cells in the brainstem, which send direct projections to several brain areas involved in satiety and energy balance, including parts of the hypothalamus that regulate hunger. The net effect is that your brain receives a much louder and longer-lasting “you’re full” signal than it would from a normal meal. Many people on semaglutide describe it as food simply occupying less mental space: cravings quiet down, portions naturally shrink, and the urge to snack between meals fades.
Why Your Stomach Empties Slower
Semaglutide also acts on the digestive tract itself, slowing the rate at which food moves from your stomach into your small intestine. This delayed gastric emptying keeps you feeling full longer after eating and helps blunt the blood sugar spike that normally follows a meal.
The effect is measurable. In one retrospective analysis of patients undergoing upper endoscopy, 24% of those taking semaglutide had significant residual food in their stomachs, compared to just 5% of people not on the drug. This slower emptying contributes to the appetite suppression but is also the primary reason for the most common side effects.
Why Nausea Is So Common
The same mechanisms that make semaglutide effective are responsible for its side effects. Delayed gastric emptying means food sits in the stomach longer than your body expects, which can trigger nausea, bloating, and sometimes vomiting. On top of that, the brainstem pathways that semaglutide activates to produce satiety are physically close to, and overlap with, the brain circuits that control nausea. Both central signals from the brain and peripheral signals from the gut through vagal nerve pathways contribute to these symptoms.
For most people, the nausea is worst during the dose-escalation period (when the dose is gradually increased over several weeks) and tends to fade as the body adjusts. Constipation is another common complaint, caused by reduced intestinal motility along the entire digestive tract. These aren’t signs that something is going wrong; they’re a predictable consequence of the drug doing exactly what it’s designed to do.
Effects Beyond Blood Sugar and Weight
Semaglutide appears to have benefits that go beyond its original purpose. The SELECT trial, one of the largest cardiovascular outcomes studies of its kind, found that the 2.4 mg weekly dose reduced major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) by 20% compared to placebo in people with pre-existing heart disease and obesity who did not have diabetes.
As of 2025, the FDA has also approved semaglutide (under the brand name Wegovy) for treating a form of fatty liver disease called metabolic dysfunction-associated steatohepatitis, or MASH, in adults with moderate to advanced liver scarring. That approval came through an accelerated pathway, meaning it’s based on improvements in liver tissue rather than long-term clinical outcomes, and confirmatory trials are still underway. A warning about acute kidney injury from dehydration (often related to vomiting and diarrhea side effects) was also added to the label in 2025, along with updated guidance about the risk of pulmonary aspiration during general anesthesia, since delayed gastric emptying means patients may have undigested food in their stomachs even after fasting.
Putting It All Together
Ozempic works on multiple systems simultaneously, which is part of why it’s been so effective for both diabetes and weight management. It increases insulin release when blood sugar is high. It suppresses the hormone that tells your liver to make more sugar. It slows digestion so meals last longer. And it activates brain pathways that reduce hunger and food preoccupation. Each of these effects reinforces the others: slower digestion helps control blood sugar spikes, reduced appetite leads to fewer calories, and better blood sugar control reduces the insulin surges that promote fat storage.
The once-weekly dosing works because the drug’s fatty acid modification lets it circulate in the blood for days, bound to albumin. Researchers have even developed prodrug versions that extend the half-life to roughly 36 days, potentially enabling once-monthly dosing in the future. But the core mechanism stays the same: a synthetic version of a hormone your gut already makes, engineered to last long enough to reshape how your body handles food and energy around the clock.